Vinge advised Abliva on the deal. Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of...
You must be a Standard 1 Year member to access this content.
Vinge advised Carasent on the deal. Carasent AB (publ) completed the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent...
You must be a Standard 1 Year member to access this content.
Vinge advised Symrise on the deal. Symrise AG announced a public cash offer to the shareholders of Probi AB (publ). The offer values Probi at approximately...
You must be a Standard 1 Year member to access this content.
Vinge advised EQT X on the deal. EQT X, through its indirectly owned subsidiary Oak BidCo S.à r.l., secured an ownership of 72.5% of the votes...
You must be a Standard 1 Year member to access this content.
Vinge advised Cantargia on the deal. Cantargia AB (publ) secured a rights offering of approximately SEK 170 million. Cantargia develops antibody based therapies against the target...
You must be a Standard 1 Year member to access this content.
Vinge advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission,...
You must be a Standard 1 Year member to access this content.
Vinge advised Nordic Paper on the deal. Strategic Value Partners, through Coniferous Bidco AB, executed a public takeover offer to the shareholders in Nordic Paper Holding...
You must be a Standard 1 Year member to access this content.
Squire Patton Boggs and Vinge advised ITAB Shop Concept AB. ITAB Shop Concept proposed the acquisition of the HMY Group to LBO France. HMY Group is...
You must be a Standard 1 Year member to access this content.
Vinge advised La Française des Jeux SA on the deal. La Française des Jeux SA, France’s national lottery and leading betting and gaming operator, announced a...
You must be a Standard 1 Year member to access this content.
Vinge advised Active Biotech on the offering. Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 million. Active Biotech...
You must be a Standard 1 Year member to access this content.
Vinge advised EHF on the deal. EHF AB has made a public offer for all shares in Götenehus Group AB (publ). EHF and Erik Hemberg privately...
You must be a Standard 1 Year member to access this content.
Vinge advised Cantargia AB on the deal. Cantargia AB (publ) completed a directed share issue of approximately SEK 59 million (approx. $5.4 million) to a number of...
You must be a Standard 1 Year member to access this content.
